Collectively, we conclude that most NSCLC lines show either (i) an NAMPT-independent ability to maintain the NAD pool or (ii) a GAPDH-independent ability to maintain energy status, or both. The gene discussed is GAPDH; the disease is non-small cell lung carcinoma.